Physician-run telehealth — TN · FL · GA · OH · WA. One doctor reviews every case. No queue, no chatbot.
Pillar 3 of 4 — Our GLP-1 Philosophy

The dose doesn’t just climb. It pauses on purpose.

A dose that only ever climbs never gives your body — or the habits you’re building around it — a chance to catch up. Summit builds in two separate kinds of pause: one triggered by your own plateau, and one triggered by distance traveled.

What “stalled for 8–12 weeks” actually means

Weight loss on GLP-1/GIP therapy rarely moves in a straight line. As you lose weight, your metabolism adapts, your appetite hormones recalibrate, and the same dose that was working starts producing less effect — a real physiological plateau, not a failure of willpower. Summit’s protocol treats that plateau as data: once loss has genuinely stalled for 8 to 12 weeks at your current dose, that’s the signal to consider the next rung up, reviewed at your next visit.

0 25 lbs 50 lbs 75 lbs 100 lbs Time in treatment → ENGINEERED PLATEAU ENGINEERED PLATEAU ENGINEERED PLATEAU dose holds here dose holds here dose holds here
Theoretical weight-loss curve under Summit’s protocol — illustrative, not a projection for any individual patient

How to read this: this is a theoretical curve, not a prediction for you specifically — real weight loss is never this smooth. What it illustrates is the shape Dr. Miranda deliberately engineers into the plan: loss climbs toward each 25-lb milestone, then the dose intentionally holds — not because loss has necessarily stalled on its own, but because Dr. Miranda pauses it there on purpose — before the climb resumes toward the next milestone. A plan with no engineered plateaus would just be this same curve with the flat sections removed — a straight climb straight to the ceiling, with nothing built in to let your body or your habits catch up along the way.

A second layer, on top of the stall rule

Dr. Miranda’s philosophy adds a second checkpoint that isn’t in the escalation math at all: a deliberate pause approximately every 25 lbs lost, regardless of where that lands on the dose ladder. The stall rule asks “is this dose still working?” The 25-lb checkpoint asks a different question: “has enough changed — your labs, your habits, your relationship with food and exercise — that we should take stock before going any further?” Both questions matter, and they don’t always line up on the same visit.

What actually happens during a hold

A hold isn’t a pause in your care — your monthly visit still happens. Dr. Miranda reviews injection technique and site rotation, checks in on the daily fundamentals (hydration, electrolytes, protein intake), and orders labs as indicated. No dose change is made during a hold; the point is confirmation, not inaction.

Why this specifically prevents the common failure mode

Programs that escalate on a fixed calendar risk two things at once: outrunning your body’s ability to adapt, and outrunning your ability to build the habits that will actually hold the weight off later. The planned-breaks structure is what keeps those two paces — medication and behavior — roughly in step with each other, instead of the dose racing ahead of everything else.

Start your application

A program with a finish line.

Apply in about five minutes. Dr. Miranda reviews every application himself.

Summit Metabolic Health

Physician-run GLP-1 weight loss and hormone care — the only program built to get you off medication, not keep you on it.

Telehealth only · Licensed in TN · FL · GA · OH · WA
200 M.L.K. Blvd, Suite 1000, Chattanooga, TN 37402
(423) 407-7837 · pmiranda@summitmetabolic.health

LegitScript certified — verify approval for summitmetabolichealth.com
© 2026 Summit Metabolic Health. All rights reserved.

Summit Metabolic Health provides telehealth services to patients located in Tennessee, Florida, Georgia, Ohio and Washington. Content on this site is for general information and is not a substitute for individualized medical advice. Medication is prescribed only after a physician evaluation determines it is appropriate, and is dispensed and billed separately through an independent, licensed 503A compounding pharmacy. Individual results vary. Compounded medications are prepared for an individual patient by prescription and are not approved or evaluated by the FDA for safety, effectiveness, or quality. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S; Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Summit Metabolic Health is not affiliated with Novo Nordisk or Eli Lilly, and compounded semaglutide and tirzepatide are not those branded products.